Stock SQZB SQZ BIOTECHNOLOGIES COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Company SQZ Biotechnologies Company

Equities

SQZB

US78472W2035

Biotechnology & Medical Research

End-of-day quote OTC Markets
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
0.0265 USD +6.00% Intraday chart for SQZ Biotechnologies Company -46.89% +33.17%
Feb. 29 STEMCELL Technologies Canada Inc. completed the acquisition of substantially all of the assets of SQZ Biotechnologies Company. CI
2023 STEMCELL Technologies Canada Inc. entered into an asset purchase agreement to acquire substantially all of the assets of SQZ Biotechnologies Company for $11.8 million. CI

Business Summary

SQZ Biotechnologies Company is a clinical-stage biotechnology company. The Company is focused on unlocking the full potential of cell therapies to benefit patients. In oncology, it is developing cell therapy platforms that are based on directing tumor antigen-specific immune activation via engineered antigen presentation. Its clinical-stage cell therapy candidates include SQZ Enhanced APC (eAPC) Platform, SQZ Activating Antigen Carrier (AAC) Platform and SQZ Tolerizing Antigen Carrier (TAC) Platform. The SQZ eAPC platform is the second-generation product candidate designed to generate tumor specific CD8+ T cell activation to drive the antitumor immune response. The SQZ AAC platform is designed to induce antigen presentation in vivo by deriving antigen carriers from engineering red blood cells (RBCs) with tumor specific antigens and adjuvants. Its SQZ TAC platform is designed to induce antigen-specific immune tolerance in vivo by utilizing a similar approach to the AAC platform.

Number of employees: 53

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,491,125 28,872,220 ( 97.90 %) 0 97.90 %

Shareholders

NameEquities%Valuation
Polaris Growth Management LLC
10.18 %
3,003,509 10.18 % 144 168 $
AMERICAN INTERNATIONAL GROUP, INC.
8.535 %
2,517,173 8.535 % 120 824 $
NanoDimension, Inc.
4.901 %
1,445,221 4.901 % 69 371 $
Invus Public Equities Advisors LLC
3.870 %
1,141,309 3.870 % 54 783 $
Klavis Jensen
1.149 %
338,983 1.149 % 16 271 $
Amy Schulman
0.7409 %
218,514 0.7409 % 10 489 $
Howard Bernstein
0.2017 %
59,470 0.2017 % 2 855 $
Kestrel7 LLC
0.0170 %
5,000 0.0170 % 240 $
Lawrence Knopf
0.006571 %
1,938 0.006571 % 93 $
Paul Bolno
0.000000 %
0 0.000000 % - $

Company contact information

SQZ Biotechnologies Co.

200 Arsenal Yards Boulevard Suite 210

02472, Watertown

+

http://www.sqzbiotech.com
address SQZ Biotechnologies Company(SQZB)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SQZ BIOTECHNOLOGIES COMPANY Stock SQZ Biotechnologies Company
+33.17% 782K
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SQZB Stock
  4. Company SQZ Biotechnologies Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW